A. Navascués

发表

Population-based contact investigation of a cluster of tuberculosis cases in a small village

J. Castilla, A. Barricarte, M. García Cenoz, 2009, Epidemiology and Infection.

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases

J. Castilla, M. Guevara, I. Martínez-Baz, 2022, Scientific reports.

Surveillance for Enteroviruses Associated with Hand, Foot, and Mouth Disease, and Other Mucocutaneous Symptoms in Spain, 2006–2020

C. Launes, C. Muñoz-Almagro, G. Megias, 2021, Viruses.

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children

J. Castilla, C. Ezpeleta, A. Navascués, 2021, Human vaccines & immunotherapeutics.

Effect of Repeated Vaccination With the Same Vaccine Component Against 2009 Pandemic Influenza A(H1N1) Virus

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, The Journal of infectious diseases.

[Clinical relevance of nontuberculous mycobacteria].

A. Navascués, I. Dorronsoro, Y. Salicio, 2008, Anales del sistema sanitario de Navarra.

Detection of Respiratory Viruses in Deceased Persons, Spain, 2017

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2018, Emerging infectious diseases.

The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain

Isabel María García Sánchez, R. Cogollos, C. Toro, 2020, Scientific Reports.

Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.

X. Beristain, J. Castilla, A. Barricarte, 2012, Vaccine.

[Resistance to penicillin and other antimicrobials in 103 clinical isolations of Streptococcus pneumoniae (2000-2001)].

I. Martin, A. Navascués, C. Gastesi, 2003, Anales del sistema sanitario de Navarra.

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2022, Microbiology spectrum.

Effect of influenza vaccination in patients with asthma

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Canadian Medical Association Journal.

Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021

S. de Lusignan, H. D. de Melker, M. Valenciano, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021

G. R. Ordóñez, J. Castilla, C. Ezpeleta, 2021, Journal of clinical microbiology.

Emergence of SARS-CoV-2 variant B.1.575.2 containing the E484K mutation in the spike protein in Pamplona (Spain) May-June 2021

G. R. Ordóñez, J. Castilla, C. Ezpeleta, 2021, medRxiv.

Utility of a commercial RT-qPCR assay to detect SARS-CoV-2 gene variations as an indicator of lineages

J. Castilla, C. Ezpeleta, A. Navascués, 2021, Journal of Virological Methods.

Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons.

F. Pozo, J. Castilla, A. Barricarte, 2016, Vaccine.

[State of methicillin resistant Staphylococcus aureus in the Hospital of Navarre (2000-2002)].

A. Navascués, F. Guillén, J. J. García Irure, 2004, Anales del sistema sanitario de Navarra.

Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018

R. González-Sanz, S. Pérez-Castro, M. Cabrerizo, 2019, Emerging microbes & infections.

Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013.

X. Beristain, J. Castilla, M. Guevara, 2014, Vaccine.

Evaluation of the rapid antigen test CerTest SARS-CoV-2 as an alternative COVID-19 diagnosis technique

C. Ezpeleta, A. Navascués, C. Trobajo-Sanmartín, 2021, Infectious diseases.

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Study of the resistance of Mycobacterium tuberculosis to the principal tuberculostatics (Hospital of Navarra 1996-2003)].

A. Navascués, I. Dorronsoro, C. Gastesi, 2005, Anales del sistema sanitario de Navarra.

Effectiveness of the current and prior influenza vaccinations in Northern Spain, 2018-2019.

F. Pozo, J. Castilla, I. Martínez-Baz, 2020, Vaccine.

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Journal of clinical medicine.

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers

U. Fresán, J. Castilla, I. Martínez-Baz, 2020, Vaccines.

[Paracoccidioidomycosis in an Ecuadorian immigrant].

A. Navascués, F. Monzón, M. T. Rubio, 2013, Enfermedades infecciosas y microbiologia clinica.

[Imported histoplasmosis in Navarra: presentation of four cases].

J. Repáraz, A. Gil-Setas, A. Navascués, 2011, Revista iberoamericana de micologia.

Infections due to Cellulosimicrobium species: case report and literature review

A. Navascués, R. Juanbeltz, M. Rivero, 2019, BMC Infectious Diseases.

Hydrogen Production by Catalytic Steam Reforming of Acetol, a Model Compound of Bio-Oil

R. Bilbao, A. Navascués, M. Ramos, 2007 .

Source identification of autochthonous-introduced Plasmodium vivax Malaria, Spain

J. M. Azcona, X. Beristain, J. Castilla, 2017, Infection.

[Spontaneous bacterial peritonitis and bacteraemia due to Aeromonas hydrophila].

A. Navascués, A. Rodrigo, M. Vivanco, 2003, Anales del Sistema Sanitario de Navarra.

Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016

A. Antón, C. Launes, C. Muñoz-Almagro, 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

A. Dopazo, A. Oliver, J. Tubío, 2021, Nature Genetics.

Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season.

F. Pozo, J. Castilla, M. Guevara, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Vaccine effectiveness in preventing laboratory-confirmed influenza in Navarre, Spain: 2013/14 mid-season analysis.

F. Pozo, J. Castilla, M. Guevara, 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Hepatitis C core antigen: diagnosis and monitoring of patients infected with Hepatitis C virus.

J. Castilla, C. Ezpeleta, A. Navascués, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Bacteriemia and hepatic abscess secondary to Yersinia pseudotuberculosis infection].

A. Navascués, I. Dorronsoro, J. J. García-Irure, 2005, Enfermedades infecciosas y microbiologia clinica.

Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017

X. Beristain, C. Ezpeleta, A. Gil-Setas, 2019, Emerging infectious diseases.

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study

J. Castilla, M. Guevara, I. Martínez-Baz, 2023, Journal of Infection and Public Health.

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

J. Castilla, M. Guevara, I. Martínez-Baz, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[Bacteremia and hepatic abscess caused by Yersinia enterocolitica].

A. Navascués, Y. Salicio, J. J. García-Irure, 2004, Anales del sistema sanitario de Navarra.

[Evaluation of the MTD-2 test for the direct detection of Mycobacterium tuberculosis in specimens].

A. Navascués, I. Dorronsoro, C. Gastesi, 2005, Anales del sistema sanitario de Navarra.

Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16

J. Castilla, M. Guevara, I. Martínez-Baz, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

F. Pozo, J. Castilla, I. Martínez-Baz, 2015, Human vaccines & immunotherapeutics.

Comparison of the Risk of Hospitalization and Severe Disease Among Co-circulating Severe Acute Respiratory Syndrome Coronavirus 2 Variants.

J. Castilla, M. Guevara, C. Ezpeleta, 2022, The Journal of infectious diseases.

Effect of influenza vaccination in preventing laboratory-confirmed influenza hospitalization in patients with diabetes mellitus.

U. Fresán, J. Castilla, I. Martínez-Baz, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Remaining effect of influenza vaccines received in prior seasons.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2019, The Journal of infectious diseases.

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

F. Pozo, J. Castilla, I. Martínez-Baz, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis

F. Pozo, J. Castilla, I. Martínez-Baz, 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons

J. Castilla, I. Martínez-Baz, F. Irisarri, 2014, PloS one.

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22

F. Pozo, J. Castilla, I. Martínez-Baz, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Effect of Repeated Vaccination With the Same Vaccine Component Against Influenza A(H1N1)pdm09.

J. Castilla, I. Martínez-Baz, C. Ezpeleta, 2017, The Journal of infectious diseases.

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021

J. Castilla, M. Guevara, I. Martínez-Baz, 2021, Eurosurveillance.

Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021

M. Valenciano, G. Fagherazzi, F. Galtier, 2023, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.